03.20.26 -- STREAM Edition: The Tradeoffs Of Continuous Processing

Innovative molecular methods will allow mAbs manufacturers to deliver critical therapeutic agents to patients faster. Gain insight into a powerful tool that accelerates bulk harvest testing.

Learn about high throughput biologic automation and GMP master cell banking services as well as variable selection services that search the SQL space to find promoters.

Hear from a specialist on addressing the challenges with antibody aggregates and process related impurity removal using new resins.

 

Continuous bioprocessing has real benefits from a productivity standpoint, but it’s not inherently the best model for every process, especially in early stage development. In this segment from the Bioprocess Online Live event, our panelists discuss how and when to approach continuous manufacturing.

See how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain, enabling upstream processes that scale efficiently and reliably.

Confident GxP compliance starts with complete, connected data. Discover how a unified platform brings together experiment, process, and product information to support seamless bioprocessing.